Challenge of rechallenge: When to resume immunotherapy following an immune-related adverse event

Erica C. Nakajima, Evan J. Lipson, Julie R. Brahmer

Research output: Contribution to journalArticlepeer-review

Abstract

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.

Original languageEnglish (US)
Pages (from-to)2714-2718
Number of pages5
JournalJournal of Clinical Oncology
Volume37
Issue number30
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Challenge of rechallenge: When to resume immunotherapy following an immune-related adverse event'. Together they form a unique fingerprint.

Cite this